U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C21H23N3O7S
Molecular Weight 461.488
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LENAMPICILLIN

SMILES

[H][C@]12SC(C)(C)[C@@H](N1C(=O)[C@H]2NC(=O)[C@H](N)C3=CC=CC=C3)C(=O)OCC4=C(C)OC(=O)O4

InChI

InChIKey=ZKUKMWMSYCIYRD-ZXFNITATSA-N
InChI=1S/C21H23N3O7S/c1-10-12(31-20(28)30-10)9-29-19(27)15-21(2,3)32-18-14(17(26)24(15)18)23-16(25)13(22)11-7-5-4-6-8-11/h4-8,13-15,18H,9,22H2,1-3H3,(H,23,25)/t13-,14-,15+,18-/m1/s1

HIDE SMILES / InChI
Lenampicillin is a prodrug of ampicillin that inhibits bacterial penicillin binding proteins (transpeptidase) and thus is effective against a wide range of bacterial infections. The drug was developed and marketed in Japan (Takacillin, Varacillin), however its current marketing status is unknown and supposed to be discontinued.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
TAKACILLIN

Approved Use

Various infections including respiratory, urinary tract, skin and soft tissue, surgical, otolaryngological, ophthalmological and dental infections due to susceptible microorganism
PubMed

PubMed

TitleDatePubMed
Human carboxymethylenebutenolidase as a bioactivating hydrolase of olmesartan medoxomil in liver and intestine.
2010 Apr 16
Patents

Sample Use Guides

1,000 mg, in 4 equally divided doses
Route of Administration: Oral
In Vitro Use Guide
Unknown
Name Type Language
LENAMPICILLIN
INN   MI   WHO-DD  
INN  
Official Name English
lenampicillin [INN]
Common Name English
2,3-DIHYDROXY-2-BUTENYL(2S,5R,6R)-6-((R)-2-AMINO-2-PHENYLACETAMIDO)-3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO(3.2.0)HEPTANE-2-CARBOXYLATE, CYCLIC CARBONATE
Common Name English
Lenampicillin [WHO-DD]
Common Name English
LENAMPICILLIN [MI]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C1500
Created by admin on Sat Dec 16 17:45:17 GMT 2023 , Edited by admin on Sat Dec 16 17:45:17 GMT 2023
Code System Code Type Description
INN
5467
Created by admin on Sat Dec 16 17:45:17 GMT 2023 , Edited by admin on Sat Dec 16 17:45:17 GMT 2023
PRIMARY
CAS
86273-18-9
Created by admin on Sat Dec 16 17:45:17 GMT 2023 , Edited by admin on Sat Dec 16 17:45:17 GMT 2023
PRIMARY
EPA CompTox
DTXSID1057901
Created by admin on Sat Dec 16 17:45:17 GMT 2023 , Edited by admin on Sat Dec 16 17:45:17 GMT 2023
PRIMARY
ChEMBL
CHEMBL2106329
Created by admin on Sat Dec 16 17:45:17 GMT 2023 , Edited by admin on Sat Dec 16 17:45:17 GMT 2023
PRIMARY
PUBCHEM
65646
Created by admin on Sat Dec 16 17:45:17 GMT 2023 , Edited by admin on Sat Dec 16 17:45:17 GMT 2023
PRIMARY
NCI_THESAURUS
C90912
Created by admin on Sat Dec 16 17:45:17 GMT 2023 , Edited by admin on Sat Dec 16 17:45:17 GMT 2023
PRIMARY
SMS_ID
100000082588
Created by admin on Sat Dec 16 17:45:17 GMT 2023 , Edited by admin on Sat Dec 16 17:45:17 GMT 2023
PRIMARY
MERCK INDEX
m6761
Created by admin on Sat Dec 16 17:45:17 GMT 2023 , Edited by admin on Sat Dec 16 17:45:17 GMT 2023
PRIMARY Merck Index
MESH
C045384
Created by admin on Sat Dec 16 17:45:17 GMT 2023 , Edited by admin on Sat Dec 16 17:45:17 GMT 2023
PRIMARY
DRUG CENTRAL
1553
Created by admin on Sat Dec 16 17:45:17 GMT 2023 , Edited by admin on Sat Dec 16 17:45:17 GMT 2023
PRIMARY
EVMPD
SUB08430MIG
Created by admin on Sat Dec 16 17:45:17 GMT 2023 , Edited by admin on Sat Dec 16 17:45:17 GMT 2023
PRIMARY
FDA UNII
8M568DM08K
Created by admin on Sat Dec 16 17:45:17 GMT 2023 , Edited by admin on Sat Dec 16 17:45:17 GMT 2023
PRIMARY
CHEBI
135748
Created by admin on Sat Dec 16 17:45:17 GMT 2023 , Edited by admin on Sat Dec 16 17:45:17 GMT 2023
PRIMARY